Goldman Sachs’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $19.5M | Buy |
|
|||||
|
2023
Q1 | $8.09M | Buy |
|
|||||
|
2022
Q4 | $5.56M | Sell |
|
|||||
|
2022
Q3 | $7.92M | Buy |
|
|||||
|
2022
Q2 | $4.09M | Sell |
|
|||||
|
2022
Q1 | $3.84M | Buy |
|
|||||
|
2021
Q4 | $3.56M | Buy |
|
|||||
|
2021
Q3 | $2.49M | Buy |
|
|||||
|
2021
Q2 | $2.17M | Buy |
|
|||||
|
2021
Q1 | $294K | Sell |
|
|||||
|
2020
Q4 | $330K | Buy |
|
|||||
|
2020
Q3 | $157K | Sell |
|
|||||
|
2020
Q2 | $544K | Buy |
|
|||||
|
2020
Q1 | $201K | Sell |
|
|||||
|
2019
Q4 | $914K | Buy |
|
|||||
|
2019
Q3 | $156K | Sell |
|
|||||
|
2019
Q2 | $554K | Buy |
|
|||||
|
2019
Q1 | $1.01M | Buy |
|
|||||
|
2018
Q4 | $651K | Buy |
|
|||||
|
2018
Q3 | $1.13M | Sell |
|
|||||
|
2018
Q2 | $1.3M | Sell |
|
|||||
|
2018
Q1 | $3.62M | Buy |
|
|||||
|
2017
Q4 | $2.21M | Buy |
|
|||||
|
2017
Q3 | $2.06M | Sell |
|
|||||
|
2017
Q2 | $2.52M | Sell |
|
|||||
|
2017
Q1 | $2.54M | Buy |
|
|||||
|
2016
Q4 | $627K | Buy |
|
|||||
|
2016
Q3 | $326K | Buy |
|
|||||
|
2016
Q2 | $264K | Sell |
|
|||||
|
2016
Q1 | $617K | Buy |
|
|||||
|
2015
Q4 | $1.03M | Buy |
|